Company news

Immutep Ltd news in 2018

Immutep Ltd's news releases, calls and decks from 2018, newest first.

View company

Cleansing prospectus for issue of warrants

December 19, 2018

European patent granted for IMP321 & antibody combinations

November 28, 2018

Immutep granted European patent for IMP321

November 27, 2018

Positive interim TACTI-mel data presented at SITC

November 11, 2018

Immutep enters into collaboration with Pfizer & Merck KGaA

September 23, 2018

Progress towards clinical development of IMP761

September 2, 2018

Appendix 4E & 2018 Full Year Statutory Accounts

August 21, 2018

TACTI-mel Patient Recruitment Complete & Operational Update

August 6, 2018

Immutep receives IND approval from US FDA for IMP321

July 31, 2018

Immutep submits IND application with FDA

July 2, 2018

Mid-point of patient enrolment reached in AIPAC trial

June 18, 2018

Webcast slides for TACTI-mel clinical trial data

May 29, 2018

Response to ASX Price Query

May 15, 2018

Immutep raises A$6.85M through institutional placement

March 11, 2018

US patent grant for IMP701 antibody

March 5, 2018

Immutep receives A$686,704 R&D Tax Incentive

March 4, 2018

Outcome of DSMB Safety Review & Extension of TACTI-mel

February 8, 2018

Immutep receives USD1M milestone payment from EOC

February 1, 2018

Decks in 2018